We describe the substantial shortfall in adherence to guideline-recommended albumin-to-creatinine ratio (uACR) testing for people in the United States with type 2 diabetes. Poor compliance with current guidelines leads to delays in diagnosis-and treatment- of chronic kidney disease, which adversely affects clinical outcomes and contributes to incremental economic burden.
Keywords: Albuminuria; Chronic kidney disease; T2D; Type 2 diabetes; uACR.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.